The test delivers clear results within 30 minutes for a negative result, and as fast as 11 minutes for a positive result.
No prescription necessary
Free ground shipping (or pay more for overnight shipping on business days)
Purchase as many tests as you need
Upload your test results into the secure LUCI portal to share verified test results on your smartphone
Available to individuals aged 14+
Available in all 50 states
Single-use test kit including: 2 AA batteries, a test unit, sample vial, swab, and plastic disposal bag
No returns or refunds
1. Excluding samples with very low levels of virus (>37.5 Ct), Lucira Community Testing Study 07A-CLI 006 Fall 2020 and Lucira Community Testing Study 07A-CLI 007 Winter 2021 (n=394)
About the EUA
This test kit has not been FDA cleared or approved, but has been authorized for emergency use by FDA under an EUA;
This test kit has been authorized only for the testing of nasal swabs for detection of nucleic acid from SARS-CoV-2, not for any other viruses or pathogens.
The emergency use of this test kit is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID19 under Section 564(b)(1) of the Federal Food, Drug, and Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless the declaration is terminated or authorization is revoked sooner.
Indications for Use
The Lucira Check It COVID-19 Test Kit is a single-use test kit intended to detect the novel coronavirus SARS-CoV-2 that causes COVID-19. This test is authorized for over-the-counter (OTC) use with self-collected nasal swab samples in individuals with or without COVID-19 symptoms aged 14 and older, and in children aged 2-13 collected by an adult. This test is similar to a PCR test in that it utilizes a molecular amplification technology for the detection of SARS-CoV-2 RNA. Positive results are indicative of the presence of SARS-CoV-2. Individuals who test positive should self-isolate and seek additional care from their healthcare provider. Positive results do not rule out bacterial infection or co-infection with other viruses. Negative results do not preclude SARS-CoV-2 infection. Individuals who test negative and continue to experience COVID-like symptoms should seek follow up care from their healthcare provider. Negative results are presumptive and confirmation with a molecular assay performed in a laboratory, if necessary, for patient management may be performed. For use under the Food and Drug Administration’s Emergency Use Authorization only. Test results can be reported through the LUCI secure portal, to relevant public health authorities in accordance with local, state, and federal requirements.
Please find links to the test kit package insert, long-form instructions, information for healthcare providers and information about the FDA Emergency Use Authorization: